A bill to amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.

Summary

Amends the Federal Food, Drug, and Cosmetic Act to prohibit a holder of a new, approved drug application from manufacturing, marketing, selling, or distributing a generic version of such drug during any exclusivity period granted to manufacturers of generic brands.

This text is taken from the official record. PoliticalRepo does not editorialize.

Timeline

1. 19 July 2006

   Introduced

   Read twice and referred to the Committee on Health, Education, Labor, and Pensions. (text of measure as introduced: CR S7928)

   Source: IntroReferral

2. 19 July 2006

   Introduced

   Introduced in Senate

   Source: IntroReferral

3. 19 July 2006

   Introduced

   Sponsor introductory remarks on measure. (CR S7927)

   Source: IntroReferral

Votes

No vote records are attached yet.

Versions

• Introduced in Senate · 19 July 2006 · Official file

Documents

3 official files

• Introduced in Senate (text)

  Introduced in Senate · EN · 19 July 2006

  ViewDownloadOpen at official source

• Introduced in Senate (PDF)

  Introduced in Senate · EN · 19 July 2006

  ViewDownloadOpen at official source

• Introduced in Senate

  summary · EN · 19 July 2006

  Open at official source

Sponsors

• Sen. Rockefeller, John D., IV [D-WV] · D · Sponsor
• Charles Schumer · D · Sponsor
• Sen. Leahy, Patrick J. [D-VT] · D · Sponsor
• Sen. Kohl, Herb [D-WI] · D · Cosponsor
• · sshr00 · Standing

Related records

• related to → To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs.